Copy For Citation
Şenkal N., Meral R., Medetalibeyoğlu A., Konyaoğlu H., Kose M., Tukek T.
Anatolian journal of cardiology, vol.24, no.1, pp.21-29, 2020 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
24
Issue:
1
-
Publication Date:
2020
-
Doi Number:
10.14744/anatoljcardiol.2020.57431
-
Journal Name:
Anatolian journal of cardiology
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.21-29
-
Keywords:
coronavirus disease 2019, angiotensin-converting enzyme 2, angiotensin II receptor type 1 blockers, angiotensin-converting enzyme inhibitors, ANGIOTENSIN-CONVERTING ENZYME-2, SARS-CORONAVIRUS, FUNCTIONAL RECEPTOR
-
Istanbul University Affiliated:
Yes
Abstract
Objective: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Renin-angiotensin-aldosterone-system (RAAS) inhibitors may increase the expression of angiotensin-converting enzyme 2, which is the receptor for SARSCoV-2 Spike protein. The consequences of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) during the COVID-19 pandemic are unknown.